Cost-minimization study comparing Simulect versus Thymoglobulin in renal transplant induction

Transplant Proc. 2001 Nov-Dec;33(7-8):3197-8. doi: 10.1016/s0041-1345(01)02360-0.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Antilymphocyte Serum / economics
  • Antilymphocyte Serum / therapeutic use*
  • Basiliximab
  • Cost Control
  • Cyclosporine / economics
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • France
  • Hospitalization / economics
  • Humans
  • Kidney Transplantation / immunology*
  • Postoperative Complications / economics
  • Postoperative Complications / epidemiology
  • Recombinant Fusion Proteins*

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Recombinant Fusion Proteins
  • Cyclosporine
  • Basiliximab